Oruka Therapeutics (ORKA) earnings, Aug 10, 2026: EPS −20%, stock −0.4%
In brief
Oruka Therapeutics reported on Aug 10, 2026. Earnings per share changed −20% year over year, 7.3% below the estimate; revenue 0%. The stock opened with a +2.3% gap and closed the day −0.4% (Aug 11, 2026). The stock is now 16.9% below its 52-week high, +251.6% over 12 months. Next report: Nov 18, 2026.
EPS vs estimate−7.3%
EPS, YoY−20%
Revenue, YoY0%
Gap · day+2.3% · −0.4%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 13, 2026 | +0.3% | +1.1% |
| Aug 10, 2026 | +2.3% | −0.4% |
Next-quarter estimates, ratings and the ORKA chart are in the terminal.
Open the terminalFAQ
When is Oruka Therapeutics's next earnings report?
Nov 18, 2026. The date comes from daily data and is corrected if the company moves it.
How did Oruka Therapeutics stock react to the report?
Opening gap +2.3%, day's result −0.4%.
Did Oruka Therapeutics's earnings grow?
Earnings per share fell 20% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.